BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26457007)

  • 1. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
    Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
    Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
    Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
    PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
    Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
    Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis.
    Wurbel MA; McIntire MG; Dwyer P; Fiebiger E
    PLoS One; 2011 Jan; 6(1):e16442. PubMed ID: 21283540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
    J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.
    Trivedi PJ; Bruns T; Ward S; Mai M; Schmidt C; Hirschfield GM; Weston CJ; Adams DH
    J Autoimmun; 2016 Apr; 68():98-104. PubMed ID: 26873648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.
    López-Pacheco C; Soldevila G; Du Pont G; Hernández-Pando R; García-Zepeda EA
    Mediators Inflamm; 2016; 2016():3635809. PubMed ID: 27795621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of indole inhibitors of chemokine receptor 9 (CCR9).
    Pandya BA; Baber C; Chan A; Chamberlain B; Chandonnet H; Goss J; Hopper T; Lippa B; Poutsiaka K; Romero J; Stucka S; Varoglu M; Zhang J; Zhang X
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3322-3325. PubMed ID: 27256913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.
    Yokoyama W; Kohsaka H; Kaneko K; Walters M; Takayasu A; Fukuda S; Miyabe C; Miyabe Y; Love PE; Nakamoto N; Kanai T; Watanabe-Imai K; Charvat TT; Penfold ME; Jaen J; Schall TJ; Harigai M; Miyasaka N; Nanki T
    Arthritis Res Ther; 2014 Sep; 16(5):445. PubMed ID: 25248373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR9 and CCL25: A review of their roles in tumor promotion.
    Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
    J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
    Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
    Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
    Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
    Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
    Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
    Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
    Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
    Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
    Atanes P; Lee V; Huang GC; Persaud SJ
    Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyrate functions in concert with myeloid-derived suppressor cells recruited by CCR9 to alleviate DSS-induced murine colitis.
    Xiao T; Zhang P; Feng T; Lu K; Wang X; Zhou S; Qiang Y
    Int Immunopharmacol; 2021 Oct; 99():108034. PubMed ID: 34426112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
    Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
    Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR9+ plasmacytoid dendritic cells in the small intestine suppress development of intestinal inflammation in mice.
    Mizuno S; Kanai T; Mikami Y; Sujino T; Ono Y; Hayashi A; Handa T; Matsumoto A; Nakamoto N; Matsuoka K; Hisamatsu T; Takaishi H; Hibi T
    Immunol Lett; 2012 Aug; 146(1-2):64-9. PubMed ID: 22626536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.